OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A
Young‐Chae Kim, Sunmi Seok, Yang Zhang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Role and Mechanism of Gut Microbiota in Human Disease
Yinwei Chen, Jinghua Zhou, Li Wang
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 451

New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 98

Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis
Takeshi Katafuchi, Makoto Makishima
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6046-6046
Open Access | Times Cited: 89

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Joshua S. Fleishman, Sunil Kumar
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 77

FGF-based drug discovery: advances and challenges
Gaozhi Chen, Lingfeng Chen, Xiaokun Li, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4

The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Ting Hong, Yiyan Chen, M Kellis, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 69

Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation
Shirong Wang, Lin Zha, Xin Cui, et al.
Advanced Science (2023) Vol. 10, Iss. 20
Open Access | Times Cited: 31

Fibroblast growth factor 15/19 expression, regulation, and function: An overview
Gregory Guthrie, Caitlin Vonderohe, Douglas G. Burrin
Molecular and Cellular Endocrinology (2022) Vol. 548, pp. 111617-111617
Open Access | Times Cited: 29

Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols
Kevin M. Tveter, Esther Mezhibovsky, Yue Wu, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108457-108457
Open Access | Times Cited: 21

Bile acid metabolism and signaling in liver disease
Claudia Fuchs, Benedikt Simbrunner, Maximillian Baumgartner, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 8

Regulation of bile acids and their receptor FXR in metabolic diseases
Yao Li, Lulu Wang, Yi Qing, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 7

L‐Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism
Wei Xu, Yingying Kong, Tuo Zhang, et al.
Journal of the Science of Food and Agriculture (2022) Vol. 103, Iss. 3, pp. 1283-1293
Closed Access | Times Cited: 26

Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis
Ye Tian, Matthew J. Jellinek, Kritika Mehta, et al.
Hepatology (2023)
Closed Access | Times Cited: 15

Alterations of DNA methylation profile in peripheral blood of children with simple obesity
Yi Ren, Peng Huang, Xiaoyan Huang, et al.
Health Information Science and Systems (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5

Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance
Nadejda Bozadjieva-Kramer, Jae Hoon Shin, Ziru Li, et al.
JCI Insight (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 5

Roles of fibroblast growth factors in the treatment of diabetes
Chunye Zhang, Ming Yang
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 392-402
Open Access | Times Cited: 4

Natural Compounds Exert Anti‐Obesity Effects by Regulating Cytokines
Yu Zhang, Guize Feng, Weidong Zhang, et al.
Phytotherapy Research (2025)
Closed Access

Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver
Sunmi Seok, Hao Sun, Young‐Chae Kim, et al.
Diabetes (2020) Vol. 70, Iss. 3, pp. 733-744
Open Access | Times Cited: 29

New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
Yadi Wang, Liang-Liang Wu, Xiaoyan Qi, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 799-812
Open Access | Times Cited: 17

Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice
Hao Sun, Sunmi Seok, Hyun-Kyung Jung, et al.
Molecular Metabolism (2022) Vol. 66, pp. 101603-101603
Open Access | Times Cited: 17

Gut microbiota therapy in gastrointestinal diseases
Hanif Ullah, Safia Arbab, Chengting Chang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets
Yi Chu, Yang Su, Xiaodong Chen
Pharmacology & Therapeutics (2025), pp. 108844-108844
Closed Access

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
Yun Li, Huiqin Hou, Xianglu Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21

FGF1 ameliorates obesity‐associated hepatic steatosis by reversing IGFBP2 hypermethylation
Jie Wang, Feng Zhang, Weiwei Yang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top